Search

Search Constraints

You searched for: Author/Creator Cleator, Susan

Search Results

1. 09. Is Neoadjuvant Radiotherapy Prior to Mastectomy and Autologous Reconstruction Safe? Comparisons between PRADA Trial Patients and Historical Controls. Issue 5 (May 2019)

2. 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. Issue 10191 (29th June 2019)

5. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Issue 10237 (23rd May 2020)

6. P109. Primary Radiotherapy And Deep inferior epigastric artery perforator (DIEP) flAp study (PRADA): Aesthetic Outcome and Patient Satisfaction at one year. Issue 5 (May 2019)

7. P118: Neoadjuvant radiotherapy prior to mastectomy and autologous breast reconstruction attenuates treatment times. Issue 6 (June 2020)

8. Pre-operative Radiotherapy And Deep Inferior Epigastric Artery Perforator (DIEP) flAp study (PRADA): Aesthetic outcome and patient satisfaction at one year. (March 2023)

9. Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study. Issue 5 (May 2022)

10. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. Issue 5 (May 2020)